tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Vosser, 22 are a BUY (48.89%), 10 are a HOLD (22.22%), 13 are a SELL (28.89%).
Analyst Richard Vosser, currently employed at JPMORGAN, carries an average stock price target met ratio of 50% that have a potential upside of 8.82% achieved within 124 days.
Richard Vosser’s has documented 83 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 05-Dec-2023.
Analyst best performing recommendations are on MOR (MORPHOSYS AG ADR).
The best stock recommendation documented was for MOR (MORPHOSYS AG ADR) at 12/5/2023. The price target of $8.5 was fulfilled within 6 days with a profit of $0.92 (12.14%) receiving and performance score of 20.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$160
$72.63 (83.13%)
$160
1 months 27 days ago
(06-Nov-2024)
4/16 (25%)
$54.64 (51.86%)
104
Buy
$160
$72.63 (83.13%)
$115
6 months 23 days ago
(10-Jun-2024)
2/3 (66.67%)
$16.37 (11.40%)
92
Buy
$120
$32.63 (37.35%)
11 months 10 days ago
(23-Jan-2024)
6/6 (100%)
$15.17 (14.47%)
59
Sell
$73.24
$-14.13 (-16.17%)
$68.53
11 months 17 days ago
(16-Jan-2024)
0/5 (0%)
$-32.57 (-30.78%)
Buy
$123.4
$36.03 (41.24%)
$114.85
1 years 28 days ago
(05-Dec-2023)
10/10 (100%)
$24.28 (24.50%)
159
What Year was the first public recommendation made by Richard Vosser?
